Peer Review History
| Original SubmissionJune 17, 2022 |
|---|
|
PONE-D-22-17412Opening to deaths: A discrete choice experiment about Covid-19’s policy preferences in PortugalPLOS ONE Dear Dr. Filipe, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 11 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Karyn Morrissey Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Acknowledgments Section of your manuscript: "We are grateful to Nova Health Economics and Management Knowledge Centre, the Portuguese Association of Health Economics and the Erasmus Choice Modelling Centre. This report is independent research funded by the National Institute for Health Research (NIHR) Applied Research Collaboration North West Coast (ARC NWC). The views expressed in this publication are those of the authors and not necessarily those of the NHS, NIHR, or the Department of Health and Social Care. There are neither financial nor non-financial conflicts. No ethical considerations apply." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "This report is independent research funded by the National Institute for Health Research (NIHR) Applied Research Collaboration North West Coast (ARC NWC). The views expressed in this publication are those of the authors and not necessarily those of the NHS, NIHR, or the Department of Health and Social Care. There are neither financial nor non-financial conflicts. No ethical considerations apply." Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical. 4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 5. Please ensure that you refer to Figure 1 in your text as, if accepted, production will need this reference to link the reader to the figure. 6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Comments for the Author Thank you for the opportunity to review this manuscript. This study used DCE methods to examine the preferences pertaining to consequences of COVID-19 policies in Portugal. There have been other studies using DCEs (in other countries) that have examined consequences from COVID-19 policies, however the manuscript has referenced these studies appropriately. This study offers a different perspective from other the DCEs investigating COVID-19 policies in that the study is unique for the experience in Portugal, but more interestingly, they have conducted the study at a later timepoint where the population have already experienced prior lockdowns/COVID-19 restrictions, thereby capturing sentiment in subsequent waves. There are comments, which should be addressed by the authors, and changes that need clarification. General comments • The term ‘willingness to pay (WTP)’ is used to describe the marginal rate of substitution (MRS) for attribute levels, using death (as a continuous variable) as the numeraire. Using the term WTP is confusing as a cost attribute were not used in the DCE. The authors should change the wording throughout the manuscript to reflect that the MRS were measured rather than WTP. • Data were collected when vaccination were available. Did the survey collect data about vaccination? Is this a factor that may potentially affect the results given that this study reports on the preferences of subsequent waves? This could be included in the discussion section. Section comments Introduction • Line 63: “We find that avoiding deaths ……” is one of the results found. Please delete this line from the introduction. • Lines 64-65: see comment below regarding the data analysis (under methodology) pertaining to method used to assess heterogeneity. Methodology • Data analysis: The major limitation in this manuscript pertains to the analysis used, which was conditional logit modelling, followed by subgroup analyses to explore heterogeneity. Although conditional logit models are typically used to initially analyse DCE data, and there are better methods that could be used when exploring heterogeneity. The authors should consider using other methods e.g., mixed logit modelling or latent class analysis, to explore heterogeneity within the sample. I’ve noted some references the authors may wish to review1-4. Including these analyses would require a substantial change to the manuscript; however, this would improve the manuscript and interpretation pertaining to heterogeneity. • Under statistical analysis, please state the software used to analyse the data; and under survey (line 171-172) include the software used to create the D-optimal design. • Section 3.2: o Line 117-118: “The attributes were chosen based on international literature (Chorus 2020 and Reed 2020)”; as these are DCEs it would be better to state that other DCEs were used to inform this study. o Line 120: Change “attributed” to “attribute”. o Line 120-122: Is there a reference that could be included referencing the policies at the time of the survey? • Survey, line 173: Were any changes made after the pilot study? If yes, please note the changes that were made. Was the data from the pilot used in the final analysis of the DCE? • Table S1: move the example of the choice set into the main text rather than the appendix. Noting that the choice question is likely in Portuguese, could you translate and include the question respondents were asked to answer in their choice task? This is good for a reader to get an overview of what was explicitly asked to do in the DCE. • Line 186-187: The sentence “We divided our analysis of the respondents characteristics into three groups: individual, household, and work-related aspects” is unclear. Can you clarify what this refers to and how these groupings were used? I’m assuming each term is an umbrella term for other more specific terms, which should be clarified in the text. • Lines 193-195: Euros are denoted after the numeric figure and should be placed before the number. • Did you collect any information from the respondents about their experience in completing this DCE? Was there any feedback they had given about any of the survey? If not, add as a note in the limitations section. • Lines 215-217: The results for the conditional logit indicate that the levels for death were treated categorically. Can you please clarify this in the text? This is clarified for the MRS analysis, but not the conditional logit analysis. • Section 3.4: the model equations available in the appendix are perhaps not needed. It may be better to reference a textbook which readers can refer to. Alternatively, specify the equations to be specific for this DCE if they wish to retain. Results • The main results section may need to be rewritten. The difference in the levels should be explained relative to the base level, which is not clear in the text, especially if readers are not familiar with DCEs. For example, relative to 50 deaths, respondents do not prefer 250 deaths, or something to that effect. • line 226: Reword text “which serve as baseline” to the “which serves as the baseline level”. • Line 226-227: “education and life restrictions have statistically indistinguishable coefficients for levels medium and high.” This is unclear, can you please clarify this text. • Table 3: Both the conditional logit (using death as a categorical variable) and the MRS (using death as a continuous variable) are reported in this table. I suggest merging Table 3 and Table S3 in the appendix to form one table e.g., models across the column headings and attributes and levels as rows, then move this table to the appendix. For the results, graph in a forest plot, as this is better visually for a reader. Please report model statistics models for the results (e.g., number of observations, AIC, BIC, loglikelihood) in the table. • Figure 1: Willingness-to-pay (WTP) by subgroups: It is difficult to read the bars for each group, can you redo the bars so that teach of the groups are not overlapping? Alternatively present the more interesting one in the main body (gender and workplace), and make these larger, and move other categories to the appendix. • Line 248-249: Two characteristics are noted as having statistically significant dfferences in preference. Under analysis, can you include what tests were run to determine statistical signifcance and report the results in the text in this section. • Line 253: as you have used a continuous variable, please rephrase the sentence such that the “lower number of deaths avoided” is quantified as per the MRS. Discussion • Line 262 and line 290: Change the term “utility” to “preferences” as this was the outcome being estimated. Please change all instances throughout manuscript. • Line 302: A comparison with the general population is made with reference to income. However, the baseline characteristics table does not report the comparative income for the general population. I can understand this may be the case, but I think this should be rephrased somewhat or a reference included noting what the mean or median income is for Portugal. • The higher risk of poverty is an interesting finding pertaining to the MRS results. The 45% level being described as a catastrophic scenario and the implications, could be described in more detail in the discussion. If space is an issue, the discussion pertaining to women could be shortened. • Line 272-274: Rephrase sentence “During the pandemic ….” • Another limitations to include in the discussion is that the highest level for deaths in the DCE was below the maximum level. 1 Lancsar E, Fiebig DG, Hole AR. Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. PharmacoEconomics 2017; 35: 697-716. 2 Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health 2011; 14: 403-413. 3 Hauber AB, González JM, Groothuis-Oudshoorn CG, et al. Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force. Value Health 2016; 19: 300-315. 4 Reed Johnson F, Lancsar E, Marshall D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health 2013; 16: 3-13. Reviewer #2: Comments for authors This is an interesting paper on public preferences for COVID controls using DCEs. I have some major and some minor comments. My major concerns are around the design and implementation of the survey and the way you present some of the results. Major comments 1. I’m not sure your title “Opening to deaths” really encapsulates the breadth of analysis in your paper. 2. In terms of the duration covered, you used “January to June 2021”, it would be good to see the choice card/full questionnaire in Portuguese to be able to see what the respondents were looking at. I have to say that this is a little bit vague to me and could be interpreted as either being 5 or 6 months depending on how you read it. Was there a reason you chose 6 months? I also find it a bit strange that you are asking about the past as well to some – as this was conducted until March 2021. 3. I have some concerns over the designs and levels. First, can you comment on having both a poverty level and income level in the same choice experiment. These are both income levels at the end of the day – I wonder if you can reflect on that (and if e.g. employment might be better to use if this is to be repeated?). 4. In terms of the educational impairment – why was a % of students used rather than a level of education days lost? The latter seems to be more of a realistic measure. Surely most are affected in some way by a lockdown. 5. In Table 2 you present the descriptive statistics for income as being “household income” but in the text this is presented as being “per individual” – this is a bit confusing. Is there not also a potential issue that this income level has been impacted by COVID - did you consider asking the “pre-COVID” level? This might affect how you interpret the results in terms of the household income loss being presented as percentages… and this is also I imagine the reason you are not able to report national level percentage rates (though you could use the latest Census?). 6. It is good to see that the authors obtained ethical clearance from an ethics board in Portugal. I just want the authors to confirm that there was approval for data collection with those under 18 (as 28.79% of the sample in Table 2 is being reported as being <18). If not explicit, then the authors may need to clarify that they have such approval from the Nova Business School ethics committee – I realise open surveys of this type are hard to control. You might want to rephrase line 347 – there clearly are ethical considerations in this kind of survey! 7. I must say I find it a bit surprising that given the age distribution of the sample that only 28% have no college degree – presumably the majority of under 18s and about half of the next age group would not be of the age to have a college degree. 8. I find it strange that you use “Willingness to Pay” and use a deaths metric as the basis for it (rather than a euro value). Maybe you could rephrase this? “Death acceptance”? (though admittedly there is a difference between “willingness to accept” and “willingness to pay” – I have a feeling here that acceptance may be a better phrase!). When you talk of things like “women have a lower WTP than men” in my mind that suggests they value life less, when in fact this is the opposite! 9. I am wondering if it would be worth thinking about what your results would imply if you translated this (via the income change) to a Value of a Prevented Fatality – a rough calculation I have done suggests the numbers you are getting are pretty low (which might reflect the perception that older and those more likely to die sooner are those most at risk). 10. Given that this was very much a time of much change in terms of COVID regulation and information, I am wondering if you have considered including examining whether these preferences had any time element – e.g. if there was any systematic difference between the responses in March compared to those in January. 11. I think there is a question you may want to think about in terms of uncertainty of a pandemic spread on health. In your experiment you use fixed numbers – when the epidemiological modelling of risked deaths would probably be much higher (given the deaths on a day when things were controlled was higher than your 250 number). It might be worth reflecting on this and the implications this has on the use of DCEs in this context. DCEs do take some time to design and implement/analyse – so compared to focus groups and other forms of surveys this may restrict their applicability. Sampling, as you note, is also important (given your sample is not representative). Minor comments: 1. Line 27 and Line 326 – I don’t think “auscultate” is quite the right word – my understanding is that this is more a medical term (I will have to admit I had to look up what it meant). Perhaps consider using “assess” instead – which I think conveys what you mean. 2. Line 305 – “the NHS” – not clear what this is (I’m presuming you mean the SNS in Portugal but would be better to specify – as you also use the NHS on line 346 to refer to UK NHS). ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-22-17412R1Trade-offs during the COVID-19 pandemic: a discrete choice experiment about policy preferences in PortugalPLOS ONE Dear Dr. Filipe, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 16 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Karyn Morrissey Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Comments for the Author Thank you for making changes to your initial manuscript. The change in title is better than the original title proposed. The authors have addressed some of the main issues, but I think the paper needs another revision before it is ready for publication. The main points I made in the initial review pertain to the analyses that were conducted. Although the authors didn’t include a mixed logit analysis, they have revised the analysis to include a latent class analysis which improves the manuscript. The conditional logit (CL) analysis and corresponding subgroup analyses extending from the CL models have been retained in the manuscript but are not sufficient to explain the inferences made concerning heterogeneity, which the authors do note in their response. There are other issues I’ve noted with respect to the MRS results (which may be typos) that need to be reconciled. For example, the abstract notes “Estimates suggest that individuals would be willing to sacrifice 20% of their income to avoid 47 deaths per day….”; however, results in the table denote this should probably be for the level of household income being 30% (Table S2). The authors should check all the results in the tables correspond with the text. There are other instances in the abstract and the results (on page 14 paragraph 1 lines 261-267) where this is inconsistent and should be updated. On page 17 (lines 281-282, and 284-285) the wording with respect to the comparison between the subgroups such as men and women is difficult to understand - “This means that women, …… and everyday life restrictions”. Giving an interpretation for both groups within the subgroup, similar to what you have when you are discussing the main results e.g., (assuming 2 corresponds to the mid-level and 3 corresponds to the worst level perceived) would improve readability e.g., the women were willing to sacrifice 20% of their income to avoid seven daily deaths, whereas the men were willing to sacrifice 20% of their income to avoid 17 daily deaths. There are still quite a few typos and grammar issues, for example, consistency in the tense used and numeric formatting, and I have noted a few of these below. Other comments Line 95-96: “during three fortnights” is odd phrasing; perhaps change to “over a six week period”. Where numeric figures are below 10, please write out value in full e.g., line 104 – “5” to “five”. The numeric formatting should be consistent throughout the manuscript e.g., line 99 “1.516”, line 215 “1,250 euro”, line 219 “€1750”, lines 220-224 where decimal places in the text pertaining to percentages are written as either no decimal places or to one or two decimal places; remove the decimal from all numeric figures that are in the thousands throughout. e.g., “1.516”, “6.994”. etc. Line 141-142: “ the attribute of percentage of impaired students is used as a proxy for “number of education days lost…”. This is not a major issue, but maybe add something about the framing of this attribute, as I don’t think it does refer to the number of education days lost. The basis of the attribute appears to be ‘person-based and does not quite reflect “hours lost”. I’d probably add this as a limitation in the discussion if you want to discuss it further. Overall phrasing under Section 3.4 p10: I think some of the wording used in the manuscript should be changed to make it easier to read. For example: Line 211: “Respondents’ age ranged from 18 up to over 85 years old” to “Respondents aged 18 years and over”; Line 211: Delete the words “Concentration is high in young ages” Line 214-215: “Considering on the differences in household’s size and composition, individuals display a median monthly equivalised income of around 1,250 euros”. It should be made clear whether it is the study sample or the population. Results and attributes and levels: “social restrictions” and “life restrictions” are used interchangeably. Are these the same? What was given to the respondents? That probably should be used consistently in the manuscript. Line 283: “observed” would be better to use than “verified”. Another instance in the discussion. Latent class analysis: In your response I can see you tested models with 2 or 3 classes. Did you test whether model fit using CAIC and BIC beyond three latent classes? You should add a statement in your manuscript confirming whether the three class model was the best model fit based on CAIC and BIC parameters and the range of model with different classes tested. The summary of results requires more careful review. For example in line 292, it states that Class 1 is “more affected by household income losses and poverty losses”; which is not quite the case. A stronger aversion to household income reducing by 30% is observed in Class 3 (reference class) compared to Class 1. In line 293-294, the text noting “It (Class 1) has a higher prevalence of males… “ should be reworded. For example “people with Class 1 preferences a more likely to be male and work remotely”. In lines 343-345 in the discussion i.e., “higher share of males …..”. Please rephrase as noted above. People with Class X preferences are more likely to have characteristics such as …… Is there a reference you used for calculating the relative importance of the attributes as shown in Figure 3? ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Trade-offs during the COVID-19 pandemic: a discrete choice experiment about policy preferences in Portugal PONE-D-22-17412R2 Dear Dr. Filipe, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Karyn Morrissey Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-17412R2 Trade-offs during the COVID-19 pandemic: a discrete choice experiment about policy preferences in Portugal Dear Dr. Filipe: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Karyn Morrissey Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .